Lifestance Health (LFST) | Financial Analysis & Statements
Lifestance Health Group Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
382.2M
Gross Profit
126.3M
33.04%
Operating Income
18.1M
4.73%
Net Income
11.7M
3.05%
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
682.9M
Shareholders Equity
1.5B
Debt to Equity
0.45
Cash Flow Metrics
Operating Cash Flow
61.9M
Free Cash Flow
46.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Lifestance Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.3B | 1.1B | 859.5M | 667.5M |
| Cost of Goods Sold | 963.2M | 848.6M | 753.6M | 622.5M | 466.0M |
| Gross Profit | 461.1M | 402.4M | 302.1M | 237.0M | 201.5M |
| Gross Margin % | 32.4% | 32.2% | 28.6% | 27.6% | 30.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 382.2M | 363.1M | 410.8M | 378.0M | 433.7M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 382.2M | 363.1M | 410.8M | 378.0M | 433.7M |
| Operating Income | 24.1M | -31.6M | -189.1M | -210.2M | -286.4M |
| Operating Margin % | 1.7% | -2.5% | -17.9% | -24.5% | -42.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 11.7M | 26.5M | 21.2M | 19.9M | 38.9M |
| Other Non-Operating Income | -123.0K | 535.0K | 3.8M | -2.6M | -7.8M |
| Pre-tax Income | 12.4M | -57.6M | -206.6M | -232.7M | -333.1M |
| Income Tax | 2.7M | -170.0K | -20.3M | -17.2M | -25.9M |
| Effective Tax Rate % | 21.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 9.7M | -57.4M | -186.3M | -215.6M | -307.2M |
| Net Margin % | 0.7% | -4.6% | -17.6% | -25.1% | -46.0% |
| Key Metrics | |||||
| EBITDA | 78.8M | 39.0M | -108.8M | -141.2M | -233.7M |
| EPS (Basic) | $0.03 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
| EPS (Diluted) | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
| Basic Shares Outstanding | 386016000 | 379147000 | 367457000 | 355278000 | 327523000 |
| Diluted Shares Outstanding | 386016000 | 379147000 | 367457000 | 355278000 | 327523000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Lifestance Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 248.6M | 154.6M | 78.8M | 108.6M | 148.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 95.7M | 131.8M | 125.4M | 100.9M | 76.1M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 19.9M | 14.9M | 10.7M | 11.0M | 11.7M |
| Total Current Assets | 416.2M | 312.5M | 225.7M | 233.2M | 266.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 150.8M | 148.7M | 171.5M | 200.4M | 1.0M |
| Goodwill | 2.8B | 2.8B | 2.8B | 2.8B | 2.7B |
| Intangible Assets | 177.7M | 190.8M | 221.1M | 263.3M | 300.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 5.4M | 7.7M | 10.9M | 10.8M | 3.4M |
| Total Non-Current Assets | 1.8B | 1.8B | 1.9B | 1.9B | 1.7B |
| Total Assets | 2.2B | 2.1B | 2.1B | 2.2B | 1.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 18.9M | 25.7M | 23.2M | 24.4M | 24.6M |
| Short-term Debt | 60.0M | 56.7M | 46.5M | 38.8M | 1.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 282.0K | 542.0K | 11.9M | 18.8M | 14.8M |
| Total Current Liabilities | 252.0M | 228.9M | 202.9M | 176.0M | 116.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 414.5M | 428.5M | 461.6M | 437.7M | 157.4M |
| Deferred Tax Liabilities | 16.4M | 14.3M | 15.6M | 38.7M | 54.3M |
| Other Non-Current Liabilities | 68.0K | 309.0K | 952.0K | 2.8M | 53.6M |
| Total Non-Current Liabilities | 431.0M | 443.1M | 478.2M | 479.1M | 265.3M |
| Total Liabilities | 682.9M | 672.0M | 681.0M | 655.1M | 382.1M |
| Equity | |||||
| Common Stock | 3.9M | 3.8M | 3.8M | 3.8M | 3.7M |
| Retained Earnings | -808.6M | -818.3M | -760.8M | -572.6M | -357.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.4B | 1.4B | 1.5B | 1.5B |
| Key Metrics | |||||
| Total Debt | 474.5M | 485.2M | 508.1M | 476.5M | 158.7M |
| Working Capital | 164.2M | 83.6M | 22.9M | 57.2M | 149.8M |
Balance Sheet Composition
Lifestance Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 9.7M | -57.4M | -186.3M | -215.6M | -307.2M |
| Depreciation & Amortization | 54.8M | 71.0M | 80.4M | 69.2M | 54.1M |
| Stock-Based Compensation | 74.7M | 76.2M | 99.4M | 187.4M | 259.4M |
| Working Capital Changes | -13.6M | -52.6M | -67.3M | -27.2M | -23.6M |
| Operating Cash Flow | 172.9M | 77.0M | -50.5M | 39.2M | -30.8M |
| Investing Activities | |||||
| Capital Expenditures | -36.1M | -21.6M | -40.5M | -79.3M | -94.5M |
| Acquisitions | 0 | 0 | -19.8M | -60.2M | -99.6M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -36.1M | -21.6M | -60.3M | -139.5M | -194.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 287.8M | 57.8M | 257.3M | 98.8M |
| Debt Repayment | -7.2M | -289.5M | -2.5M | -187.8M | -311.4M |
| Financing Cash Flow | -16.0M | -9.9M | 47.4M | 47.3M | 313.9M |
| Free Cash Flow | 110.0M | 85.7M | -57.4M | -26.5M | -85.1M |
| Net Change in Cash | 120.8M | 45.4M | -63.4M | -53.0M | 89.0M |
Cash Flow Trend
Lifestance Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
345.25
Forward P/E
18.06
Price to Book
1.76
Price to Sales
1.86
PEG Ratio
18.06
Profitability Ratios
Profit Margin
0.68%
Operating Margin
4.74%
Return on Equity
0.65%
Return on Assets
0.73%
Financial Health
Current Ratio
1.65
Debt to Equity
31.20
Beta
1.13
Per Share Data
EPS (TTM)
$0.02
Book Value per Share
$3.92
Revenue per Share
$3.69
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LFST | 2.7B | 345.25 | 1.76 | 0.65% | 0.68% | 31.20 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pacs | 5.5B | 28.73 | 5.80 | 22.96% | 3.62% | 377.77 |
| Chemed | 5.6B | 20.88 | 5.36 | 25.28% | 10.48% | 14.68 |
| Option Care Health | 4.5B | 22.35 | 3.36 | 15.20% | 3.67% | 96.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.





